NDC 82497-132 – Rolvedon
Eflapegrastim 13.2 mg/.6mL · Injection, Solution · Subcutaneous
Product NDC82497-132
Product details
- Brand name
- Rolvedon
- Generic name
- Eflapegrastim-xnst
- Labeler
- Assertio Specialty Pharmaceuticals, LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761148
- Marketed since
- December 11, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Leukocyte Growth Factor
Active ingredients
- Eflapegrastim 13.2 mg/.6mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 82497-132-01 | .6 mL in 1 SYRINGE, GLASS (82497-132-01) | Dec 11, 2025 |
Other Rolvedon products
- 76961-101 Eflapegrastim 13.2 mg/.6mL · Injection, Solution · Spectrum Pharmaceuticals, Inc.